project id: TCGA-LGG; case submitter id: TCGA-DB-A4XH; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.46; rna integrity number: 7.1; age at index: 53; days to birth: -19710; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 19710; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 962.0; icd 10 code: C71.1; last known disease status: not reported; morphology: 9382/3; primary diagnosis: Mixed glioma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Frontal lobe; synchronous malignancy: No; tissue or organ of origin: Frontal lobe; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 397; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-DB-A4XH-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 35.0; percent stromal cells: 5.0; percent tumor cells: 60.0; percent tumor nuclei: 85.0;